“Market access is the complex and protracted process that pharma and biotech companies have to go through in order to ensure that their medicines are made available in as many countries as possible, while ensuring these medicines are reimbursed and made available to the patients who need them.” (Ver)
No hay comentarios:
Publicar un comentario